| Value | ₹6,325 Cr |
|---|
BSE filing, NSE: LICI. Summary written from the filing by ALFA Finder's alert engine.
Life Insurance Corporation of India: key numbers
- Share price
- ₹391.45
- Market cap
- ₹4,95,184 Cr
- Revenue (annual)
- ₹9,77,772 Cr
- Net profit (annual)
- ₹57,453 Cr
- P/E (TTM)
- 8.2×Sector 19.7×
- Promoter holding
- 90.00%-6.50% QoQ
- FII holding
- 1.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Life Insurance Corporation of India
All →Life Insurance Corporation of India Other Announcement
This is a quarterly shareholding pattern filing for Life Insurance Corporation of India for the period ended September 30, 2026.
Life Insurance Corporation of India Board Meeting Date
LIC intimated that its Board is scheduled for 05 Nov 2026 to approve Q2 and half-year financial results. Trading window for insiders is closed from 01 Oct 2026 until 48 hours post-meeting.
Life Insurance Corporation of India Product Launch
Life Insurance Corporation of India is launching three new insurance products—LIC's New Jeevan Dhara-II, Health Shield, and New Cancer Cover—effective October 19, 2026.
Life Insurance Corporation of India Management Change
LIC has appointed five new Independent Directors, including Shailesh Kumar Singh and David Paul Rasquinha, for a term of four years effective October 07, 2026.
Life Insurance Corporation of India Management Change
Life Insurance Corporation of India announced the voluntary retirement of Shri Dinesh Pant as Managing Director. He ceased to be a Key Managerial Personnel on September 24, 2026.
Life Insurance Corporation of India Product Launch
Life Insurance Corporation of India is launching two new individual insurance products, LIC’s Bima Platinum and LIC’s Jeevan Raksha. Both products will be available for sale from September 7, 2026.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.